This compound is a quinazoline derivative used as a reference standard for afatinib impurity testing. It serves as a quality control material in pharmaceutical manufacturing and analytical laboratories.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2413212-07-2
(S)-N4-(3,4-Difluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
pharmaceutical intermediate
N4-(3-chloro-4-fluorophenyl)-7-(((3S)-tetrahydro-3-furanyl)oxy)-4,6-quinazolinediamine
pharmaceutical raw material
(R)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine
pharmaceutical raw material
Desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib
pharmaceutical raw material
(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)
pharmaceutical raw material
Afatinib N-oxide
pharmaceutical raw material
Isavuconazole
pharmaceutical raw material
Isoconazole nitrate
pharmaceutical raw material
4-N-(4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine
DCBBEFYNODKZDK-ZDUSSCGKSA-N
C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC=C(C=C4)F)N